• Search
  • Helpdesk
  • Sales contact

DCT and health disparities: Insights from a patient advocate

Last updated: August 29, 2024

Basile Trimbur, Medical and Scientific Officer, Patient Engagement Lead at Kayentis, interviews Trishna Bharadia, Health Advocate & Patient Engagement Advisor, on decentralized clinical trials and their impact on health disparities.

Some of the topics covered in this interview are:

  • Can the gap between the number of patients reaching trials and the study recruitment needs be partially explained by trust issues between patients and the healthcare system? Can DCT help fix this situation? And how?
  • How would Trishna advise the industry so that we ensure that DCT do not increase the burden and become counter-productive?
  • Are DCTs a solution to reduce health disparities?


Listen to the full interview:

Trishna Bharadia
Health Advocate & Patient Engagement Advisor

Basile Trimbur
Medical & Scientific Officer, Patient Advocacy Lead

Follow us on social media
Subscribe to our newsletter
About the author
Meet us at the following events

The critical importance of Patient Reported Outcomes (PROs) for Emerging Biopharma Companies – Webinar

July 9 • 11-12AM EDT / 4-5PM GMT / 5-6PM CET
In today’s competitive landscape, biotech and emerging biopharma companies (EBPs) must demonstrate the value of their innovations early and convincingly....

DPHARM 2025

SEPT 16-17 2025 • Philadelphia, PA, USA
Booth #44 16th Annual Outsourcing in Clinical Trials East Coast 2025 - Arena International

SCDM 2025

Baltimore, Maryland, USA - 27-30 SEPT 2025
Annual Conference 2025 – SCDMLive    

SCOPE Europe 2025

OCT 14-15 2025 • Barcelona, Spain
SCOPE Europe | Summit for Clinical Operations Executives | October 14-15, 2025 |Barcelona, Spain